Skip to main content

This website is intended exclusively for healthcare professionals residing and/or working in the UAE.

Home | go to homepage
SCIENCE
  • SCIENCE
  • Cardiovascular
    • Cardiovascular
    • Thrombosis
    • Dyslipidemia
    • Atherothrombosis
  • Atopic Dermatitis
  • Diabetes
  • Asthma
  • Nasal Polyps
  • Rare Diseases
  • Vaccines
    • Vaccines
    • Influenza
    • Pertussis & Polio
    • Meningitis
  • Multiple Sclerosis
  • Prurigo Nodularis
PATIENT SUPPORT
  • PATIENT SUPPORT
  • Diabetes
    • Diabetes
    • Tools And Resources
      • Tools And Resources
      • Digital Patient Support Program
      • Pre-Ramadan Assessment Tools
      • Toujeo Welcome Pack
      • Soliqua Welcome Pack
  • Atopic Dermatitis
  • Rare Diseases
  • Nasal Polyps
  • Cardiovascular
    • Cardiovascular
    • Dyslipidemia
PRODUCTS
  • PRODUCTS
  • Dupixent®
    • Dupixent®
    • Atopic Dermatitis
    • Asthma
    • Nasal Polyps
  • Clexane®
  • Plavix®
  • Zympass®
  • Apidra®
  • Soliqua®
    • Soliqua®
    • Soliqua®
    • SoliMix Study
    • For a Peaceful Ramadan
  • Toujeo®
    • Toujeo®
    • Toujeo®
    • For a Peaceful Ramadan
    • Time-in-Range
  • Lantus®
  • Praluent®
    • Praluent®
    • Praluent®
    • Praluent 300 mg
  • Aubagio®
  • Depakine®
  • Lemtrada®
  • Amaryl®
  • Aprovel®
Home | go to homepage
Home | go to homepage
SCIENCE
  • SCIENCE
  • Cardiovascular
    • Cardiovascular
    • Thrombosis
    • Dyslipidemia
    • Atherothrombosis
  • Atopic Dermatitis
  • Diabetes
  • Asthma
  • Nasal Polyps
  • Rare Diseases
  • Vaccines
    • Vaccines
    • Influenza
    • Pertussis & Polio
    • Meningitis
  • Multiple Sclerosis
  • Prurigo Nodularis
PATIENT SUPPORT
  • PATIENT SUPPORT
  • Diabetes
    • Diabetes
    • Tools And Resources
      • Tools And Resources
      • Digital Patient Support Program
      • Pre-Ramadan Assessment Tools
      • Toujeo Welcome Pack
      • Soliqua Welcome Pack
  • Atopic Dermatitis
  • Rare Diseases
  • Nasal Polyps
  • Cardiovascular
    • Cardiovascular
    • Dyslipidemia
PRODUCTS
  • PRODUCTS
  • Dupixent®
    • Dupixent®
    • Atopic Dermatitis
    • Asthma
    • Nasal Polyps
  • Clexane®
  • Plavix®
  • Zympass®
  • Apidra®
  • Soliqua®
    • Soliqua®
    • Soliqua®
    • SoliMix Study
    • For a Peaceful Ramadan
  • Toujeo®
    • Toujeo®
    • Toujeo®
    • For a Peaceful Ramadan
    • Time-in-Range
  • Lantus®
  • Praluent®
    • Praluent®
    • Praluent®
    • Praluent 300 mg
  • Aubagio®
  • Depakine®
  • Lemtrada®
  • Amaryl®
  • Aprovel®
  • LOGIN
  • REGISTER
  • SEARCH
    • Home
    • Sanofi in News

    Sanofi in News

    Discover headline news on how Sanofi is engaged with the medical community.

    Sanofi signs multi-pronged partnership with Dasman Diabetes Institute to intensify diabetes prevention in Kuwait

    Saudi Health Council, Sanofi partner to boost diabetes studies and research in the kingdom

    Home | go to homepage

    SANOFI, Level 3, One JLT, Jumeirah Lake Towers (JLT), DMCC, PO Box 53899, Dubai, UAE | Tel.: +971 4 550 3600 | Fax: +971 4 5521050

    For further Medical Information: please contact: 800 MEDICAL Toll-Free Number,

    Email: medical-information.gulf@sanofi.com

    To report an adverse event: please call: +971 561747001 or

    Email: Gulf.pharmacovigilance@sanofi.com

    To report any product technical complaints, kindly contact:

    Email: quality.greatergulf@sanofi.com

    MAT-AE-2100444/V2/Nov 2021

    • Legal notice
    • Cookie policy
    • Privacy policy
    • Sitemap
    • Change country

    YOU WILL NOW BE LEAVING THE SITE

    By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
    Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.

    Continue
    This website is intended exclusively for healthcare professionals residing and/or working in the UAE.
     
    Please choose if you are a healthcare professional and wish to continue on this site or if you are a member of the public to be redirected to the Sanofi website.